Corpus ID: 52976194

Efficacy and Safety of the Biosimilar Recombinant Human Parathyroid Hormone Cinnopar® in Postmenopausal Osteoporotic Women: A Randomized Double-blind Clinical Trial

@article{TabatabaeiMalazy2018EfficacyAS,
  title={Efficacy and Safety of the Biosimilar Recombinant Human Parathyroid Hormone Cinnopar® in Postmenopausal Osteoporotic Women: A Randomized Double-blind Clinical Trial},
  author={O. Tabatabaei-Malazy and Masumeh Norani and R. Heshmat and M. Qorbani and Afsaneh Vosoogh and Behnaz Afrashteh and Farzin Kahkeshan and A. Ajami and B. Larijani},
  journal={Iranian Journal of Public Health},
  year={2018},
  volume={47},
  pages={1336 - 1344}
}
  • O. Tabatabaei-Malazy, Masumeh Norani, +6 authors B. Larijani
  • Published 2018
  • Medicine
  • Iranian Journal of Public Health
  • Background: Due to high cost and burden of osteoporosis, it is reasonable to focus on the reduction of fractures as the main goal of treatment. We compared the efficacy and safety of a new biosimilar recombinant human parathyroid hormone (CinnoPar®, CinnaGen, Iran) to the reference product (Forteo®, Eli Lilly, USA) in a randomized double-blind clinical trial (RCT). Methods: Overall, 104 osteoporotic postmenopausal women aged 45–75 yr were randomized to receive 20 μg daily subcutaneous… CONTINUE READING
    3 Citations
    Update on the safety and efficacy of teriparatide in the treatment of osteoporosis
    • 9
    Rheumatology training and research in Iran
    • 4

    References

    SHOWING 1-10 OF 49 REFERENCES
    A comparison of teriparatide and calcitonin therapy in postmenopausal Asian women with osteoporosis: a 6‐month study*
    • 23
    Effects of abaloparatide, a human parathyroid hormone-related peptide analog, on bone mineral density in postmenopausal women with osteoporosis.
    • 137
    • PDF
    Treatment of postmenopausal women with osteoporosis with PTH(1–84) for 36 months: treatment extension study
    • 21
    Randomized trial of once-weekly parathyroid hormone (1-84) on bone mineral density and remodeling.
    • 46
    • PDF
    The relative efficacy of nine osteoporosis medications for reducing the rate of fractures in post-menopausal women
    • 77